FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

nicholas moore

Research Profile

Geographic Areas

France

Concepts & Ideas

Chemicals & Drugs

Procedures

Activities & Behaviors

Occupations

Pharmacoepidemiology

Co-author Network

Publications

TOP 3
nicholas moore; Ezgi Gulmez; P Blin
Is paracetamol hepatotoxic at normal doses?
Amélie Daveluy; V Gilleron; A Couret; A Kostrzewa; L Lacoin; C Lecomte; Ghada Miremont-Salamé; nicholas moore; Françoise Haramburu
Identification of abuse and dependence cases through a hospital database.
F Salvo; M C Sturkenboom; F Bazin; A P Caputi; Annie Fourrier-Réglat; M Haag; nicholas moore; A Pariente; N Riera-Guardia; P Robinson
Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of nicholas moore (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: nicholas moore; Ezgi Gulmez; P Blin
Is paracetamol hepatotoxic at normal doses?
BMJ (Clinical research ed.) 2013;346():f1519.
2012: Amélie Daveluy; V Gilleron; A Couret; A Kostrzewa; L Lacoin; C Lecomte; Ghada Miremont-Salamé; nicholas moore; Françoise Haramburu
Identification of abuse and dependence cases through a hospital database.
Pharmacoepidemiology and drug safety 2012;21(12):1344-9.
2011: F Salvo; M C Sturkenboom; F Bazin; A P Caputi; Annie Fourrier-Réglat; M Haag; nicholas moore; A Pariente; N Riera-Guardia; P Robinson
Cardiovascular and gastrointestinal safety of NSAIDs: a systematic review of meta-analyses of randomized clinical trials.
Clinical pharmacology and therapeutics 2011;89(6):855-66.
2011: L Orriols; P Philip; nicholas moore; A Castot; B Gadegbeku; B Delorme; M Mallaret; Emmanuel Lagarde
Benzodiazepine-like hypnotics and the associated risk of road traffic accidents.
Clinical pharmacology and therapeutics 2011;89(4):595-601.
2010: Annie Fourrier-Réglat; L Lacoin; A Pariente; R Lassalle; P Robinson; C Droz-Perroteau; Bernard Bégaud; P Blin; nicholas moore
When patients report diseases that prescribers seem unaware of: discordance between patient and physician reporting of risk-related previous history in NSAID users from the CADEUS study.
Clinical pharmacology and therapeutics 2010;88(5):668-75.
2009: nicholas moore
No obvious extra cardiovascular risk associated with low-dose NSAIDs.
Clinical pharmacology and therapeutics 2009;86(6):600-1; author reply 602-4.
2009: Amélie Daveluy; Cécile Raignoux; Ghada Miremont-Salamé; Pierre-Olivier Girodet; nicholas moore; Françoise Haramburu; mathieu molimard
Drug interactions between inhaled corticosteroids and enzymatic inhibitors.
European journal of clinical pharmacology 2009;65(7):743-5.
2009: Christophe Dupont; Jimmy Lee Kok Foo; Philippe Garnier; nicholas moore; Hèlène Mathiex-Fortunet; Eduardo Salazar-Lindo
Oral diosmectite reduces stool output and diarrhea duration in children with acute watery diarrhea.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2009;7(4):456-62.
2009: Pernelle Noize; Fabienne Bazin; Carole Dufouil; Nathalie Lechevallier-Michel; Marie Laure Ancelin; Jean-François Dartigues; Christophe Tzourio; nicholas moore; Annie Fourrier-Réglat
Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study.
Pharmacoepidemiology and drug safety 2009;18(4):310-9.
2009: Rajaa Lagnaoui; Marie Tournier; Yola Moride; Christina Wolfson; Thierry Ducruet; Bernard Bégaud; nicholas moore
The risk of cognitive impairment in older community-dwelling women after benzodiazepine use.
Age and ageing 2009;38(2):226-8.
2009: nicholas moore
Homoeopathic product licence. Being useless may be useful.
BMJ (Clinical research ed.) 2009;338():b2334.
2009: Bruno Fantino; nicholas moore
The self-reported Montgomery-Asberg Depression Rating Scale is a useful evaluative tool in Major Depressive Disorder.
BMC psychiatry 2009;9():26.
2009: Antoine Pariente; Amélie Daveluy; Anne Laribière-Bénard; Ghada Miremont-Salame; Bernard Begaud; nicholas moore
Effect of date of drug marketing on disproportionality measures in pharmacovigilance: the example of suicide with SSRIs using data from the UK MHRA.
Drug safety : an international journal of medical toxicology and drug experience 2009;32(5):441-7.
2009: Michel Rossignol; Abdelilah Abouelfath; Regis Lassalle; Yvon Merlière; Cécile Droz; Bernard Bégaud; Fanny Depont; Yola Moride; Patrick Blin; nicholas moore; Annie Fourrier-Réglat
The CADEUS study: burden of nonsteroidal anti-inflammatory drug (NSAID) utilization for musculoskeletal disorders in blue collar workers.
British journal of clinical pharmacology 2009;67(1):118-24.
2008: Antoine Pariente; Catherine Helmer; Yvon Merliere; nicholas moore; Annie Fourrier-Réglat; Jean-François Dartigues
Prevalence of cholinesterase inhibitors in subjects with dementia in Europe.
Pharmacoepidemiology and drug safety 2008;17(7):655-60.
2008: Fleur Grégoire; Antoine Pariente; Annie Fourrier-Reglat; Françoise Haramburu; Bernard Bégaud; nicholas moore
A signal of increased risk of hypoglycaemia with angiotensin receptor blockers caused by confounding.
British journal of clinical pharmacology 2008;66(1):142-5.
2008: Mireille Canal-Raffin; Mathilde Receveur; Béatrice Martinez; Karine Titier; Celine Ohayon; Isabelle Baldi; mathieu molimard; nicholas moore; Patrick Brochard
Quantification methods of folpet degradation products in plasma with HPLC-UV/DAD: application to an in vivo toxicokinetic study in rats.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2008;865(1-2):106-13.
2008: Annie Fourrier-Réglat; Cécile Droz-Perroteau; Jacques Bénichou; Fanny Depont; Michel Amouretti; Bernard Bégaud; Yola Moride; Patrick Blin; nicholas moore
Impact of prescriber nonresponse on patient representativeness.
Epidemiology (Cambridge, Mass.) 2008;19(2):186-90.
2008: M A Mittleman; Malcolm Maclure; M A Lewis; G C Hall; nicholas moore; F Giuliano; H Porst; H Hedelin; Antonio Martin-Morales; R E Sobel; R Reynolds; D B Glasser
Cardiovascular outcomes among sildenafil users: results of the International Men's Health Study.
International journal of clinical practice 2008;62(3):367-73.
2008: Patrick Waller; Keith Beard; Toine Egberts; Stephen Evans; Jesper Hallas; Joerg Hasford; Joan-Ramon Laporte; nicholas moore; Saad Shakir; Miriam Sturkenboom
European commission consultation on pharmacovigilance.
Pharmacoepidemiology and drug safety 2008;17(2):108-9.
2008: Sébastien Vergne; Catherine Bennetau-Pelissero; Valérie Lamothe; Philippe Chantre; Mylene POTIER; Julien Asselineau; Paul Perez; Marlène Durand; nicholas moore; Patrick Sauvant
Higher bioavailability of isoflavones after a single ingestion of a soya-based supplement than a soya-based food in young healthy males.
The British journal of nutrition 2008;99(2):333-44.
2008: nicholas moore
Paracetamol with ibuprofen: Ibuprofen is a marker of soft tissue infection.
BMJ (Clinical research ed.) 2008;337():a2072.
2008: Antoine Pariente; Jean-François Dartigues; Jacques Benichou; Luc Letenneur; nicholas moore; Annie Fourrier-Réglat
Benzodiazepines and injurious falls in community dwelling elders.
Drugs & aging 2008;25(1):61-70.
2007: Patricia Sagaspe; Jacques Taillard; Guillaume Chaumet; nicholas moore; Bernard Bioulac; Pierre Philip
Aging and nocturnal driving: better with coffee or a nap? A randomized study.
Sleep 2007;30(12):1808-13.
2007: Marieke Grenouillet-Delacre; Hélène Verdoux; nicholas moore; Françoise Haramburu; Ghada Miremont-Salamé; Gabriel Etienne; Philip Robinson; Didier Gruson; Gilles Hilbert; Claude Gabinski; Bernard Bégaud; mathieu molimard
Life-threatening adverse drug reactions at admission to medical intensive care: a prospective study in a teaching hospital.
Intensive care medicine 2007;33(12):2150-7.
2007: Amélie Daveluy; Thierry Vial; Laurine Marty; Ghada Miremont-Salamé; nicholas moore; Françoise Haramburu
[Contact dermatitis caused by acetazolamide under occlusion].
Presse médicale (Paris, France : 1983) 2007;36(12 Pt 1):1756-8.
2007: Fanny Depont; Frédéric Vargas; Hervé Dutronc; Emmanuelle Giauque; Jean-Marie Ragnaud; Tatiana Galpérine; Abdelilah Abouelfath; Ruddy Valentino; Michel Dupon; Guillaume Hebert; nicholas moore
Drug-drug interactions with systemic antifungals in clinical practice.
Pharmacoepidemiology and drug safety 2007;16(11):1227-33.
2007: Yannick Arimone; Ghada Miremont-Salamé; Françoise Haramburu; mathieu molimard; nicholas moore; Annie Fourrier-Réglat; Bernard Bégaud
Inter-expert agreement of seven criteria in causality assessment of adverse drug reactions.
British journal of clinical pharmacology 2007;64(4):482-8.
2007: L Malot; mathieu molimard; A Abouelfatah; Séverine Lignot; Fanny Depont; nicholas moore; M Fayon
[Assessment of the handling of inhaler devices: an observational study of children in primary care].
Archives de pédiatrie : organe officiel de la Sociéte française de pédiatrie 2007;14(10):1190-5.
2007: Cyril Calvet; Karin Martin; Grégoire Robert; nicholas moore; Pirayeh Eftekhari; Houssam Farghal; mathieu molimard; Philippe Ballanger
[Treatment of erectile dysfunction by phosphodiesterase-5 inhibitors and nonarteritic anterior ischemic optic neuropathy (NOIAN)].
Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie 2007;17(5):920-7.
2007: Thierno Diatta; Sylvie Blazejewski; Arnaud Portier; Séverine Lignot; Ariane Quesnot; nicholas moore; Annie Fourrier-Réglat
Patterns and frequency of atypical antipsychotic prescribing in psychiatric medical centers: a cross-sectional national survey.
Fundamental & clinical pharmacology 2007;21(4):371-8.
2007: Fanny Depont; Annie Fourrier; Y Merlière; C Droz; M Amouretti; Bernard Bégaud; J Bénichou; Yola Moride; G P Velo; M Sturkenboom; P Blin; nicholas moore
Channelling of COX-2 inhibitors to patients at higher gastrointestinal risk but not at lower cardiovascular risk: the Cox2 inhibitors and tNSAIDs description of users (CADEUS) study.
Pharmacoepidemiology and drug safety 2007;16(8):891-900.
2007: Karin Martin-Latry; Marion Pinet; nicholas moore
[Increase in thyroid pathologies in France: myth or reality].
Thérapie 2007;62(4):362-4.
2007: Nadège Castaing; Karine Titier; Mathilde Receveur-Daurel; Maité Le-Déodic; Delphine Le-bars; nicholas moore; mathieu molimard
Quantification of eight new antidepressants and five of their active metabolites in whole blood by high-performance liquid chromatography-tandem mass spectrometry.
Journal of analytical toxicology 2007;31(6):334-41.
2007: Joseph Peuskens; nicholas moore; Jean-Michel Azorin; Mondher Toumi; John Cochran
The European sertindole safety and exposure survey: a follow-up study of 8600 patients.
Pharmacoepidemiology and drug safety 2007;16(7):804-11.
2007: Abdiryim Yusup; Halmurat Upur; Xirali Tursun; Benedicte Berke; Isabelle Baudrimont; nicholas moore
[Study on mechanism of abnormal savda munziq flavonoids in induction of apoptosis of Hep2 cells].
Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica 2007;32(11):1068-71.
2007: nicholas moore; Yves Juillet; Pierre-Henri Bertoye
Integrity of scientific data: transparency of clinical trial data.
Thérapie 2007;62(3):203-9, 211-6.
2007: Karine Titier; Nadège Castaing; Maité Le-Déodic; Delphine Le-Bars; nicholas moore; mathieu molimard
Quantification of tricyclic antidepressants and monoamine oxidase inhibitors by high-performance liquid chromatography-tandem mass spectrometry in whole blood.
Journal of analytical toxicology 2007;31(4):200-7.
2007: William N Kelly; Felix M Arellano; Joanne Barnes; Ulf Bergman; I Ralph Edwards; Alina M Fernandez; Stephen B Freedman; David Goldsmith; Kui Huang; Judith K Jones; Rachel McLeay; nicholas moore; Rosie H Stather; Thierry Trenque; William G Troutman; Eugene van Puijenbroek; Frank Williams; Robert P Wise
Guidelines for submitting adverse event reports for publication.
Pharmacoepidemiology and drug safety 2007;16(5):581-7.
2007: Fanny Depont; Annie Fourrier; Y Merlière; C Droz; M Amouretti; Bernard Bégaud; J Bénichou; Yola Moride; P Blin; nicholas moore
The CADEUS study: methods and logistics.
Pharmacoepidemiology and drug safety 2007;16(5):571-80.
2007: Stéphane Picard; Karine Titier; Gabriel Etienne; Emmanuelle Teilhet; Dominique Ducint; Marie-Agnes Bernard; Regis Lassalle; Gérald Marit; Josy Reiffers; Bernard Begaud; nicholas moore; mathieu molimard; François-Xavier Mahon
Trough imatinib plasma levels are associated with both cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia.
Blood 2007;109(8):3496-9.
2007: Sébastien Vergne; Karine Titier; Virginie Bernard; Julien Asselineau; Marlène Durand; Valérie Lamothe; Mylene POTIER; Paul Perez; Jacques Demotes-Mainard; Philippe Chantre; nicholas moore; Catherine Bennetau-Pelissero; Patrick Sauvant
Bioavailability and urinary excretion of isoflavones in humans: effects of soy-based supplements formulation and equol production.
Journal of pharmaceutical and biomedical analysis 2007;43(4):1488-94.
2007: Sylvie Blazejewski; Nathalie Raymond; Rajaa Lagnaoui; Stéphane Winnock; Jean-François Cochard; Laurent Petit; Jean-Pierre Dosque; Christian Fillatreau; nicholas moore
How is norepinephrine used in intensive care? A field study.
Thérapie 2007;62(2):143-9.
2007: Patricia Sagaspe; Jacques Taillard; Guillaume Chaumet; Christian Guilleminault; Olivier Coste; nicholas moore; Bernard Bioulac; Pierre Philip
Maintenance of wakefulness test as a predictor of driving performance in patients with untreated obstructive sleep apnea.
Sleep 2007;30(3):327-30.
2007: Bruno Fantino; nicholas moore; Hélène Verdoux; Jean-Paul Auray
Cost-effectiveness of escitalopram vs. citalopram in major depressive disorder.
International clinical psychopharmacology 2007;22(2):107-15.
2007: nicholas moore
Ibuprofen: a journey from prescription to over-the-counter use.
Journal of the Royal Society of Medicine 2007;100 Suppl 48():2-6.
2007: Mireille Canal-Raffin; Béatrice L'Azou; Beatrice Martinez; Elisabeth Sellier; Fawaz Fawaz; Philip Robinson; Céline Ohayon-Courtès; Isabelle Baldi; Jean Cambar; mathieu molimard; nicholas moore; Patrick Brochard
Physicochemical characteristics and bronchial epithelial cell cytotoxicity of Folpan 80 WG(R) and Myco 500(R), two commercial forms of folpet.
Particle and fibre toxicology 2007;4():8.
2007: Antoine Pariente; Fleur Gregoire; Annie Fourrier-Reglat; Françoise Haramburu; nicholas moore
Impact of safety alerts on measures of disproportionality in spontaneous reporting databases: the notoriety bias.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(10):891-8.
2007: William N Kelly; Felix M Arellano; Joanne Barnes; Ulf Bergman; Ralph I Edwards; Alina M Fernandez; Stephen B Freedman; David Goldsmith; Kui A Huang; Judith K Jones; Rachel McLeay; nicholas moore; Rosie H Stather; Thierry Trenque; William G Troutman; Eugene van Puijenbroek; Frank Williams; Robert P Wise
Guidelines for submitting adverse event reports for publication.
Drug safety : an international journal of medical toxicology and drug experience 2007;30(5):367-73.
2007: nicholas moore
Diclofenac potassium 12.5mg tablets for mild to moderate pain and fever: a review of its pharmacology, clinical efficacy and safety.
Clinical drug investigation 2007;27(3):163-95.
2007: Najim A Al-Awwadi; Anne Borrot-Bouttefroy; Anwar Umar; Cédric Saucier; Marie Claude Segur; Charles Garreau; Mireille Canal; Yves Glories; nicholas moore
Effect of Armagnac fractions on human platelet aggregation in vitro and on rat arteriovenous shunt thrombosis in vivo probably not related only to polyphenols.
Thrombosis research 2007;119(4):407-13.
2006: Emmanuel Clyti; H Théophile; J Klisnik; Amélie Daveluy; Dominique Sainte-Marie; Françoise Haramburu; nicholas moore; Pierre Couppie
[Paroxetine (Deroxat and spontaneous ecchymosis].
Annales de dermatologie et de vénéréologie 2006;133(12):1011-2.
2006: Jean-François Korobelnik; nicholas moore; Patrick Blin; Chandrabhan Dharmani; Gilles Berdeaux
Estimating the yearly number of eyes with treatable neovascular age-related macular degeneration using a direct standardization method and a markov model.
Investigative ophthalmology & visual science 2006;47(10):4270-6.
2006: Nadège Castaing; Karine Titier; Mireille Canal-Raffin; nicholas moore; mathieu molimard
Postmortem redistribution of two antipsychotic drugs, haloperidol and thioridazine, in the rat.
Journal of analytical toxicology 2006;30(7):419-25.
2006: Mathilde Daurel-Receveur; Karine Titier; Stéphane Picard; Dominique Ducint; nicholas moore; mathieu molimard
Fully automated analytical method for mycophenolic acid quantification in human plasma using on-line solid phase extraction and high performance liquid chromatography with diode array detection.
Therapeutic drug monitoring 2006;28(4):505-11.
2006: Rajaa Lagnaoui; Marie Baumevielle; Bernard Bégaud; Pierre Pouyanne; Gwenaëlle Maurice; Fanny Depont; nicholas moore
Less use of NSAIDs in long-term than in recent chondroitin sulphate users in osteoarthritis: a pharmacy-based observational study in France.
Thérapie 2006;61(4):341-6.
2006: Laurie Lévy; Corinne Martin-Guehl; Nathalie Lechevallier-Michel; Pernelle Noize; nicholas moore; Philippe Latry; Annie Fourrier-Réglat
Use of psychotropic drugs in 0 to 5 years old children in Aquitaine (France): prevalence and associated factors.
Pharmacoepidemiology and drug safety 2006;15(7):504-9.
2006: Pierre Philip; Jacques Taillard; nicholas moore; Sandrine Delord; Cédric Valtat; Patricia Sagaspe; Bernard Bioulac
The effects of coffee and napping on nighttime highway driving: a randomized trial.
Annals of internal medicine 2006;144(11):785-91.
2006: S Rambelomanana; Fanny Depont; K Forest; Guillaume Hebert; S Blazejewski; Annie Fourrier-Réglat; mathieu molimard; nicholas moore
Antidepressants: general practitioners' opinions and clinical practice.
Acta psychiatrica Scandinavica 2006;113(6):460-7.
2006: Mireille Canal-Raffin; Karine Titier; Evelyne Déridet; Béatrice Martinez; Abdelilah Abouelfath; Alain Miras; Sophie Gromb; mathieu molimard; nicholas moore
Myocardium distribution of sertindole and its metabolite dehydrosertindole in guinea-pigs.
Biopharmaceutics & drug disposition 2006;27(4):171-9.
2006: Jacques Taillard; nicholas moore; Bruno Claustrat; Olivier Coste; Bernard Bioulac; Pierre Philip
Nocturnal sustained attention during sleep deprivation can be predicted by specific periods of subjective daytime alertness in normal young humans.
Journal of sleep research 2006;15(1):41-5.
2006: Yannick Arimone; Bernard Bégaud; Ghada Miremont-Salamé; Annie Fourrier-Réglat; mathieu molimard; nicholas moore; Françoise Haramburu
A new method for assessing drug causation provided agreement with experts' judgment.
Journal of clinical epidemiology 2006;59(3):308-14.
2006: Robinson Joannides; nicholas moore; Michele Iacob; Patricia Compagnon; Guy Lerebours; Jean-François Menard; Christian Thuillez
Comparative effects of ivabradine, a selective heart rate-lowering agent, and propranolol on systemic and cardiac haemodynamics at rest and during exercise.
British journal of clinical pharmacology 2006;61(2):127-37.
2006: Marianne de Sèze; Philippe Gallien; Pierre Denys; Jean-Jacques Labat; Gérard Serment; Philippe Grise; Jean-Yves Salle; Sylvie Blazejewski; Cécile Hazane; nicholas moore; Pierre-Alain Joseph
Intravesical glucidic capsaicin versus glucidic solvent in neurogenic detrusor overactivity: a double blind controlled randomized study.
Neurourology and urodynamics 2006;25(7):752-7.
2006: Amélie Daveluy; Adélaïde Doussau de Bazignan; Frantz Thiessard; Ghada Miremont-Salamé; nicholas moore; Françoise Haramburu
[Selective serotonin reuptake inhibitors and acne].
Thérapie 2006;61(1):71-2.
2006: Ibadet Tohti; Maynur Tursun; Anwar Umar; Subat Turdi; Horyat Imin; nicholas moore
Aqueous extracts of Ocimum basilicum L. (sweet basil) decrease platelet aggregation induced by ADP and thrombin in vitro and rats arterio--venous shunt thrombosis in vivo.
Thrombosis research 2006;118(6):733-9.
2005: Pierre Philip; Patricia Sagaspe; Jacques Taillard; Cédric Valtat; nicholas moore; Torbjörn Akerstedt; André Charles; Bernard Bioulac
Fatigue, sleepiness, and performance in simulated versus real driving conditions.
Sleep 2005;28(12):1511-6.
2005: Anne Laribière; Ghada Miremont-Salamé; Hadrien Reyre; Abdelilah Abouelfath; Ludovic Liège; nicholas moore; Françoise Haramburu
Surveillance of adverse effects during a vaccination campaign against meningitis C.
European journal of clinical pharmacology 2005;61(12):907-11.
2005: Karine Titier; Stéphane Picard; Dominique Ducint; Emmanuelle Teilhet; nicholas moore; Patrice Berthaud; François-Xavier Mahon; mathieu molimard
Quantification of imatinib in human plasma by high-performance liquid chromatography-tandem mass spectrometry.
Therapeutic drug monitoring 2005;27(5):634-40.
2005: Abdiryim Yusup; Halmurat Upur; Isabelle Baudrimont; Anwar Umar; Turghun Kader; Bernard Begaud; Edmond CREPPY; nicholas moore
Cytotoxicity of abnormal Savda Munziq aqueous extract in human hepatoma (HepG2) cells.
Fundamental & clinical pharmacology 2005;19(4):465-72.
2005: nicholas moore
Online music model could work for journals.
BMJ (Clinical research ed.) 2005;330(7504):1391.
2005: Montserrat Sanchez-Ortuno; nicholas moore; Jacques Taillard; Cédric Valtat; Damien Leger; Bernard Bioulac; Pierre Philip
Sleep duration and caffeine consumption in a French middle-aged working population.
Sleep medicine 2005;6(3):247-51.
2005: Yannick Arimone; Bernard Bégaud; Ghada Miremont-Salamé; Annie Fourrier-Réglat; nicholas moore; mathieu molimard; Françoise Haramburu
Agreement of expert judgment in causality assessment of adverse drug reactions.
European journal of clinical pharmacology 2005;61(3):169-73.
2005: nicholas moore; Hélène Verdoux; Bruno Fantino
Prospective, multicentre, randomized, double-blind study of the efficacy of escitalopram versus citalopram in outpatient treatment of major depressive disorder.
International clinical psychopharmacology 2005;20(3):131-7.
2005: Pierre Philip; Patricia Sagaspe; nicholas moore; Jacques Taillard; André Charles; Christian Guilleminault; Bernard Bioulac
Fatigue, sleep restriction and driving performance.
Accident; analysis and prevention 2005;37(3):473-8.
2005: nicholas moore; Frantz Thiessard; Bernard Begaud
The history of disproportionality measures (reporting odds ratio, proportional reporting rates) in spontaneous reporting of adverse drug reactions.
Pharmacoepidemiology and drug safety 2005;14(4):285-6.
2005: Karin Martin; Fabrice Bentaberry; Chantal Dumoulin; M Longy-Boursier; François Lifermann; Françoise Haramburu; Joel Dehais; Thierry Schaeverbeke; B Bégaud; nicholas moore
Neuropathy associated with leflunomide: a case series.
Annals of the rheumatic diseases 2005;64(4):649-50.
2005: Eric Van Ganse; Judith K Jones; nicholas moore; Jean Marie Le Parc; Richard Wall; Hélène Schneid
A large simple clinical trial prototype for assessment of OTC drug effects using patient-reported data.
Pharmacoepidemiology and drug safety 2005;14(4):249-55.
2005: nicholas moore
Assessing drug safety.
BMJ (Clinical research ed.) 2005;330(7490):539-40.
2005: Mireille Canal-Raffin; Evelyne Déridet; Karine Titier; Eric Frakra; mathieu molimard; nicholas moore
Simplified ultraviolet liquid chromatographic method for determination of sertindole, dehydrosertindole and norsertindole, in human plasma.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2005;814(1):61-7.
2005: Mathilde Daurel-Receveur; Ghada Miremont-Salamé; Annie Fourrier; Pascal Auriche; nicholas moore; Bernard Bégaud; Françoise Haramburu
[Antidepressant adverse effects in the elderly: analysis of spontaneous reports in France].
Thérapie 2005;60(1):61-5.
2005: Annie Fourrier-Réglat; Ségolène de Bailliencourt; mathieu molimard; Philippe Latry; nicholas moore; Claude Peter; Bernard Bégaud
[Celecoxib prescription: data from the "Sécurité Sociale" database of the Aquitaine Region, South-Western, France].
Thérapie 2005;60(1):25-9.
2005: Bernard Bégaud; Karin Martin; Abdelilah Abouelfath; Pascale Tubert-Bitter; nicholas moore; Yola Moride
An easy to use method to approximate Poisson confidence limits.
European journal of epidemiology 2005;20(3):213-6.
2005: Yola Moride; Thierry Ducruet; Jean-François Boivin; nicholas moore; Sylvie Perreault; Sean Zhao
Prescription channeling of COX-2 inhibitors and traditional nonselective nonsteroidal anti-inflammatory drugs: a population-based case-control study.
Arthritis research & therapy 2005;7(2):R333-42.
2005: Karin Martin; Yola Moride; Colleen Metge; nicholas moore; Bernard Bégaud
Potential impact of oral contraceptive choice on myocardial infarction mortality and deep vein thrombosis.
The journal of family planning and reproductive health care / Faculty of Family Planning & Reproductive Health Care, Royal College of Obstetricians & Gynaecologists 2005;31(1):37-9.
2005: Karine Titier; Pierre-Olivier Girodet; Hélène Verdoux; mathieu molimard; Bernard Bégaud; Wilhelm Haverkamp; Malcolm Lader; nicholas moore
Atypical antipsychotics: from potassium channels to torsade de pointes and sudden death.
Drug safety : an international journal of medical toxicology and drug experience 2005;28(1):35-51.
2005: nicholas moore
Placebos in medicine: pain that is relieved by placebo is not therefore unreal.
BMJ (Clinical research ed.) 2005;330(7481):45.
2005: Anwar Umar; Fanny Depont; Alain Jacquet; Séverine Lignot; Marie Claude Segur; Michel Boisseau; Bernard Bégaud; nicholas moore
Effects of armagnac or vodka on platelet aggregation in healthy volunteers: a randomized controlled clinical trial.
Thrombosis research 2005;115(1-2):31-7.
2004: nicholas moore
Transparency and trust: Clear definition of ghost writing would be helpful.
BMJ (Clinical research ed.) 2004;329(7478):1345-6.
2004: Anwar Umar; Michel Boisseau; Abdiryim Yusup; Halmurat Upur; Bernard Bégaud; nicholas moore
Interactions between aspirin and COX-2 inhibitors or NSAIDs in a rat thrombosis model.
Fundamental & clinical pharmacology 2004;18(5):559-63.
2004: nicholas moore; Hélène Diris; Karin Martin; Raymond Viale; Annie Fourrier; Yola Moride; Bernard Bégaud
NSAID use profiles derived from reimbursement data in France.
Thérapie 2004;59(5):541-6.
2004: Rajaa Lagnaoui; Fanny Depont; Annie Fourrier; Abdelilah Abouelfath; Bernard Bégaud; Hélène Verdoux; nicholas moore
Patterns and correlates of benzodiazepine use in the French general population.
European journal of clinical pharmacology 2004;60(7):523-9.
2004: Karine Titier; Mireille Canal; Evelyne Déridet; Abdelilah Abouelfath; Sophie Gromb; mathieu molimard; nicholas moore
Determination of myocardium to plasma concentration ratios of five antipsychotic drugs: comparison with their ability to induce arrhythmia and sudden death in clinical practice.
Toxicology and applied pharmacology 2004;199(1):52-60.
2004: Joerg Hasford; nicholas moore; K Hoye
Safety and usage pattern of low-dose diclofenac when used as an over-the-counter medication: results of an observational cohort study in a community-based pharmacy setting.
International journal of clinical pharmacology and therapeutics 2004;42(8):415-22.
2004: Abdiryim Yusup; Halmurat Upur; Anwar Umar; nicholas moore
Protective effects of Munziq and Mushil of abnormal Savda to mitochondrial oxidative damage.
Fundamental & clinical pharmacology 2004;18(4):471-6.
2004: Halmurat Upur; Abdiryim Yusup; Anwar Umar; nicholas moore
Uighur traditional medicine syndrome of Abnormal Savda in men is associated with oxidative stress, which can be improved by Munziq and Mushil of Abnormal Savda.
Thérapie 2004;59(4):483-4.
2004: Marcelle-Diane Matsika; Marie Tournier; Rajaa Lagnaoui; Fabienne Pehourcq; mathieu molimard; Bernard Bégaud; Hélène Verdoux; nicholas moore
Comparison of patient questionnaires and plasma assays in intentional drug overdoses.
Basic & clinical pharmacology & toxicology 2004;95(1):31-7.
2004: Pierre Philip; Jacques Taillard; Patricia Sagaspe; Cédric Valtat; Montserrat Sanchez-Ortuno; nicholas moore; André Charles; Bernard Bioulac
Age, performance and sleep deprivation.
Journal of sleep research 2004;13(2):105-10.
2004: Karin Martin; Bernard Bégaud; Hélène Verdoux; N Lechevallier; Philippe Latry; nicholas moore
Patterns of risperidone prescription: a utilization study in south-west France.
Acta psychiatrica Scandinavica 2004;109(3):202-6.
2004: Bruno Mortemousque; A Jacquet; C Richard; Fanny Depont; Joseph Colin; nicholas moore
Randomised double masked trial comparing the efficacy and tolerance of 0.05% mequitazine eye drops versus 0.05% levocabastine and placebo in allergic conjunctivitis induced by a conjunctival provocation test with Dermatophagoides pteronyssinus.
The British journal of ophthalmology 2004;88(3):336-40.
2004: Christie M Ballantyne; Günter A J Riegger; nicholas moore; Francesco Saia; Patrick Washington Serruys
Fluvastatin reduces cardiac mortality in patients with coronary heart disease.
Cardiovascular drugs and therapy / sponsored by the International Society of Cardiovascular Pharmacotherapy 2004;18(1):67-75.
2004: Ikram Debbarh; Karine Titier; Evelyne Deridet; nicholas moore
Identification and quantitation by high-performance liquid chromatography of mancozeb following derivatization by 1,2-benzenedithiol.
Journal of analytical toxicology 2004;28(1):41-5.
2004: Karin Martin; Bernard Bégaud; Philippe Latry; Ghada Miremont-Salamé; Annie Fourrier; nicholas moore
Differences between clinical trials and postmarketing use.
British journal of clinical pharmacology 2004;57(1):86-92.
2004: Marianne de Sèze; Laurent Wiart; Mathieu-Panchoa de Sèze; Luc Soyeur; Jean-Pierre Dosque; Sylvie Blajezewski; nicholas moore; Bruno Brochet; Jean-Michel Mazaux; Michel Barat; Pierre-Alain Joseph
Intravesical capsaicin versus resiniferatoxin for the treatment of detrusor hyperreflexia in spinal cord injured patients: a double-blind, randomized, controlled study.
The Journal of urology 2004;171(1):251-5.
2003: Pierre-Olivier Girodet; Chantal Raherison; Abdelilah Abouelfath; Séverine Lignot; Fanny Depont; nicholas moore; mathieu molimard
[Real-life use of inhaler devices for chronic obstructive pulmonary disease in primary care].
Thérapie 2003;58(6):499-504.
2003: Bernard Bégaud; Annie Fourrier; nicholas moore; Yola Moride
The delusion of reducing sample size.
European journal of clinical pharmacology 2003;59(8-9):711-2.
2003: nicholas moore; Andrew Charlesworth; Eric Van Ganse; Jean-Marie LeParc; Judith K Jones; Richard Wall; Hélène Schneid; François Verrière
Risk factors for adverse events in analgesic drug users: results from the PAIN study.
Pharmacoepidemiology and drug safety 2003;12(7):601-10.
2003: Karine Titier; Nadège Castaing; Emmanuelle Scotto-Gomez; Fabienne Pehourcq; nicholas moore; mathieu molimard
High-performance liquid chromatographic method with diode array detection for identification and quantification of the eight new antidepressants and five of their active metabolites in plasma after overdose.
Therapeutic drug monitoring 2003;25(5):581-7.
2003: Rajaa Lagnaoui; nicholas moore; Yola Moride; Ghada Miremont-Salamé; Bernard Bégaud
Benzodiazepine utilization patterns in Alzheimer's disease patients.
Pharmacoepidemiology and drug safety 2003;12(6):511-5.
2003: Fanny Depont; S Rambelomanana; S Le Puil; Bernard Begaud; Hélène Verdoux; nicholas moore
Antidepressants: psychiatrists' opinions and clinical practice.
Acta psychiatrica Scandinavica 2003;108(1):24-31.
2003: nicholas moore; Gillian Hall; Miriam C J M Sturkenboom; Ron Mann; Rajaa Lagnaoui; Bernard Begaud
Biases affecting the proportional reporting ratio (PPR) in spontaneous reports pharmacovigilance databases: the example of sertindole.
Pharmacoepidemiology and drug safety 2003;12(4):271-81.
2003: Karine Titier; S Bouchet; Fabienne Péhourcq; nicholas moore; mathieu molimard
High-performance liquid chromatographic method with diode array detection to identify and quantify atypical antipsychotics and haloperidol in plasma after overdose.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2003;788(1):179-85.
2003: Anwar Umar; Viviane Guerin; Martine Renard; Michel Boisseau; Charles Garreau; Bernard Begaud; mathieu molimard; nicholas moore
Effects of armagnac extracts on human platelet function in vitro and on rat arteriovenous shunt thrombosis in vivo.
Thrombosis research 2003;110(2-3):135-40.
2003: nicholas moore; Pascale Tubert-Bitter; Annie Fourrier; Bernard Bégaud
A simple method to estimate sample sizes for safety equivalence studies using inverse sampling.
Journal of clinical epidemiology 2003;56(5):433-5.
2003: Pierre Philip; Patricia Sagaspe; Jacques Taillard; nicholas moore; Christian Guilleminault; Montserrat Sanchez-Ortuno; Torbjörn Akerstedt; Bernard Bioulac
Fatigue, sleep restriction, and performance in automobile drivers: a controlled study in a natural environment.
Sleep 2003;26(3):277-80.
2003: nicholas moore
Forty years of ibuprofen use.
International journal of clinical practice. Supplement 2003;(135):28-31.
2003: mathieu molimard; nicholas moore
How to design a negative study.
Chest 2003;123(2):655-6; author reply 656.
2003: nicholas moore
Place of OTC analgesics and NSAIDs in osteoarthritis.
Inflammopharmacology 2003;11(4):355-62.
2003: Anwar Umar; Michel Boisseau; Marie Claude Segur; Bernard Begaud; nicholas moore
Effect of age of Armagnac extract and duration of treatment on antithrombotic effects in a rat thrombosis model.
Thrombosis research 2003;111(3):185-9.
2003: mathieu molimard; Chantal Raherison; Séverine Lignot; Fanny Depont; Abdelilah Abouelfath; nicholas moore
Assessment of handling of inhaler devices in real life: an observational study in 3811 patients in primary care.
Journal of aerosol medicine : the official journal of the International Society for Aerosols in Medicine 2003;16(3):249-54.
2002: I Debbarh; S Rambelomanana; F Penouil; F Castaigne; D Poisot; nicholas moore
[Human neurotoxicity of ethylene-bis-dithiocarbamates (EBDC)].
Revue neurologique 2002;158(12 Pt 1):1175-80.
2002: nicholas moore; JM Le Parc; Eric Van Ganse; Richard Wall; Hélène Schneid; R Cairns
Tolerability of ibuprofen, aspirin and paracetamol for the treatment of cold and flu symptoms and sore throat pain.
International journal of clinical practice 2002;56(10):732-4.
2002: Bernard Bégaud; Karin Martin; Françoise Haramburu; nicholas moore
Rates of spontaneous reporting of adverse drug reactions in France.
JAMA : the journal of the American Medical Association 2002;288(13):1588.
2002: Thomas M MacDonald; Keith Beard; Rudolf Bruppacher; Joerg Hasford; Michael Lewis; Richard F Logan; David McNaughton; Pascale Tubert-Bitter; Eric Van Ganse; nicholas moore
The safety of drugs for OTC use: what evidence is required for an NSAID switch?
Pharmacoepidemiology and drug safety 2002;11(7):577-84.
2002: Christine Montout; Francoise Casadebaig; Rajaa Lagnaoui; Hélène Verdoux; Alain Philippe; Bernard Begaud; nicholas moore
Neuroleptics and mortality in schizophrenia: prospective analysis of deaths in a French cohort of schizophrenic patients.
Schizophrenia research 2002;57(2-3):147-56.
2002: nicholas moore
War on the roads. People at risk get hit by traffic.
BMJ (Clinical research ed.) 2002;325(7358):277.
2002: Karine Titier; Fabrice Lagrange; Fabienne Péhourcq; nicholas moore; mathieu molimard
Pharmacokinetic interaction between high-dose methotrexate and oxacillin.
Therapeutic drug monitoring 2002;24(4):570-2.
2002: Karine Titier; Evelyne Déridet; E Cardone; Abdelilah Abouelfath; nicholas moore
Simplified high-performance liquid chromatographic method for determination of risperidone and 9-hydroxyrisperidone in plasma after overdose.
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences 2002;772(2):373-8.
2002: Karine Titier; Fabrice Lagrange; Fabienne Péhourcq; Leila Edno-Mcheik; nicholas moore; mathieu molimard
High-performance liquid chromatographic method for the simultaneous determination of the six HIV-protease inhibitors and two non-nucleoside reverse transcriptase inhibitors in human plasma.
Therapeutic drug monitoring 2002;24(3):417-24.
2002: P Rampal; nicholas moore; Eric Van Ganse; JM Le Parc; Richard Wall; Hélène Schneid; François Verrière
Gastrointestinal tolerability of ibuprofen compared with paracetamol and aspirin at over-the-counter doses.
The Journal of international medical research 2002;30(3):301-8.
2002: Ikram Debbarh; nicholas moore
A simple method for the determination of ethylene-thiourea (ETU) in biological samples.
Journal of analytical toxicology 2002;26(4):216-21.
2002: Karine Titier; Evelyne Déridet; nicholas moore
In vivo and in vitro myocardial binding of risperidone and 9-hydroxyrisperidone.
Toxicology and applied pharmacology 2002;180(2):145-9.
2002: Karine Titier; Fabrice Lagrange; Fabienne Péhourcq; L Edno-Mcheik; nicholas moore; mathieu molimard
[Plasmatic dosage of antiretroviral drugs by high performance liquid chromathography ].
Thérapie 2002;57(2):169-74.
2002: Rajaa Lagnaoui; Bernard Bégaud; nicholas moore; Anicet Chaslerie; Annie Fourrier; Luc Letenneur; Jean-François Dartigues; Yola Moride
Benzodiazepine use and risk of dementia: a nested case-control study.
Journal of clinical epidemiology 2002;55(3):314-8.
2002: JM Le Parc; Eric Van Ganse; nicholas moore; Richard Wall; Hélène Schneid; François Verrière
Comparative tolerability of paracetamol, aspirin and ibuprofen for short-term analgesia in patients with musculoskeletal conditions: results in 4291 patients.
Clinical rheumatology 2002;21(1):28-31.
2001: Rajaa Lagnaoui; nicholas moore; Maïté Longy-Boursier; Marie Baumevieille; Bernard Bégaud
Benzodiazepine use in patients hospitalized in a department of internal medicine: frequency and clinical correlates.
Pharmacoepidemiology and drug safety 2001;10(6):531-5.
2001: Rajaa Lagnaoui; nicholas moore; Jean-François Dartigues; Annie Fourrier; Bernard Bégaud
Benzodiazepine use and wine consumption in the French elderly.
British journal of clinical pharmacology 2001;52(4):455-6.
2001: nicholas moore
Author's reply to criticism of study on benzodiazepines and risk of hip fracture.
BMJ (Clinical research ed.) 2001;323(7315):752-3.
2001: Annie Fourrier; Luc Letenneur; Jean-François Dartigues; nicholas moore; Bernard Bégaud
Benzodiazepine use in an elderly community-dwelling population. Characteristics of users and factors associated with subsequent use.
European journal of clinical pharmacology 2001;57(5):419-25.
2001: nicholas moore; C Pierfitte; Fabienne Pehourcq; Rajaa Lagnaoui; Bernard Bégaud
Comparison of patient questionnaires, medical records, and plasma assays in assessing exposure to benzodiazepines in elderly subjects.
Clinical pharmacology and therapeutics 2001;69(6):445-50.
2001: Jacques Dangoumau; Annie Fourrier; nicholas moore
[Drug evaluation in France: comparison of two approaches].
Thérapie 2001;56(3):307-14.
2001: nicholas moore
Comment on 'Quantitative estimation of rare adverse events which follow a biological progression: a new model applied to chronic NSAID use' Tramer et al., Pain 2000;85:169-182.
Pain 2001;91(3):401-2.
2001: C Pierfitte; G Macouillard; M Thicoïpe; A Chaslerie; Fabienne Pehourcq; M Aïssou; B Martinez; Rajaa Lagnaoui; Annie Fourrier; Bernard Bégaud; Jacques Dangoumau; nicholas moore
Benzodiazepines and hip fractures in elderly people: case-control study.
BMJ (Clinical research ed.) 2001;322(7288):704-8.
2001: nicholas moore
The role of the clinical pharmacologist in the management of adverse drug reactions.
Drug safety : an international journal of medical toxicology and drug experience 2001;24(1):1-7.
2000: Françoise Haramburu; Ghada Miremont-Salamé; nicholas moore
Good and bad drug prescription in pregnancy.
Lancet 2000;356(9243):1704.
2000: C Pierfitte; R J Royer; nicholas moore; Bernard Bégaud
The link between sunshine and phototoxicity of sparfloxacin.
British journal of clinical pharmacology 2000;49(6):609-12.
2000: Rajaa Lagnaoui; nicholas moore; J Fach; Maïté Longy-Boursier; Bernard Bégaud
Adverse drug reactions in a department of systemic diseases-oriented internal medicine: prevalence, incidence, direct costs and avoidability.
European journal of clinical pharmacology 2000;56(2):181-6.
2000: nicholas moore; X Verschuren; C Montout; J Callens; S X Kong; B Bégaud
Excess costs related to non-steroidal anti-inflammatory drug utilization in general practice.
Thérapie 2000;55(1):133-6.
1999: R Joannidès; nicholas moore; V de la Gueronnière; C Thuillez
Effect of water on arteries.
Lancet 1999;354(9177):516.
1999: L Abenhaim; nicholas moore; Bernard Bégaud
The role of pharmacoepidemiology in pharmacovigilance: a conference at the 6th ESOP Meeting, Budapest, 28 September 1998.
Pharmacoepidemiology and drug safety 1999;8 Suppl 1():S1-7.
1999: C Pierfitte; Bernard Bégaud; Rajaa Lagnaoui; nicholas moore
Is reporting rate a good predictor of risks associated with drugs?
British journal of clinical pharmacology 1999;47(3):329-31.
1999: Régis Bedry; L Deschamps; Fabienne Pehourcq; nicholas moore; Odile Pillet; JC Favarel-Garrigues
Non-fatal clozapine (LEPONEX) intoxication with toxicokinetic evaluation.
Veterinary and human toxicology 1999;41(1):20-2.
1998: nicholas moore; D Lecointre; C Noblet; M Mabille
Frequency and cost of serious adverse drug reactions in a department of general medicine.
British journal of clinical pharmacology 1998;45(3):301-8.
1998: Nicole Cailleux; I Marie; C Noblet; nicholas moore; L Verdure; H Lévesque; Hubert Courtois
[Amoxapine-induced pseudopheochromocytoma. Apropos of a case].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1998;19(2):139-40.
1998: mathieu molimard; nicholas moore; Bernard Begaud
Does use or withdrawal of long-acting beta 2-adrenoceptor induce desensitisation?
Lancet 1998;351(9095):66-7.
1998: Robinson Joannides; nicholas moore; Michele Iacob; Patricia Compagnon; A M Bacri; Christian Thuillez
Divergent effects of verapamil and amlodipine at rest and during exercise.
Journal of hypertension. Supplement : official journal of the International Society of Hypertension 1998;16(1):S25-9.
1997: Robinson Joannides; E H Bakkali; Franck Le Roy; O Rivault; Michel Godin; nicholas moore; Jean-Paul Fillastre; Christian Thuillez
Altered flow-dependent vasodilatation of conduit arteries in maintenance haemodialysis.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 1997;12(12):2623-8.
1997: nicholas moore; C Kreft-Jais; Françoise Haramburu; C Noblet; M Andrejak; Michel Ollagnier; Bernard Bégaud
Reports of hypoglycaemia associated with the use of ACE inhibitors and other drugs: a case/non-case study in the French pharmacovigilance system database.
British journal of clinical pharmacology 1997;44(5):513-8.
1997: Robinson Joannides; Vincent RICHARD; A Benoist; nicholas moore; Christian Thuillez
Evaluation of the determinants of flow-mediated radial artery vasodilatation in humans.
Clinical and experimental hypertension (New York, N.Y. : 1993) 1997;19(5-6):813-26.
1997: M Auriche; P Bertrand; N Blay; G Danan; J D Hamel; Jean-Louis Imbs; Georges Lagier; A Micaleff; nicholas moore; M Ollagnier; S Reveilleau-Richard; C Soubrié; F Weber
[Good practices of publication of clinical cases of pharmacovigilance: comments, Groupe de Travail sur les Bonnes Pratiques de Publication de Cliniques en Pharmacovigilance: commentary].
Thérapie 1997;52(2):123-7.
1996: Pascal Auzou; Canan Ozsancak; Didier Hannequin; nicholas moore; P Augustin
Clozapine for the treatment of psychosis in Parkinson's disease: a review.
Acta neurologica Scandinavica 1996;94(5):329-36.
1996: nicholas moore; N Vuillemin; M Abiteboul; O Boudignat; A Paliwoda; J L Robin; L D Jacobs
Large scale safety study of ketoprofen 25 mg (Toprec) in febrile and painful conditions.
Pharmacoepidemiology and drug safety 1996;5(5):295-302.
1996: nicholas moore; C Noblet; C Breemeersch
[Focus on the safety of ibuprofen at the analgesic-antipyretic dose].
Thérapie 1996;51(4):458-63.
1996: nicholas moore; C Breemeersch; C Noblet
Renal failure with fluoroquinolones.
Thérapie 1996;51(4):421-3.
1996: P Compagnon; Luc Thiberville; nicholas moore; C Thuillez; C Lacroix
Simple high-performance liquid chromatographic method for the quantitation of 5-fluorouracil in human plasma.
Journal of chromatography. B, Biomedical applications 1996;677(2):380-3.
1995: nicholas moore; C Noblet; C Kreft-Jais; G Lagier; Michel Ollagnier; J L Imbs
[French pharmacovigilance database system: examples of utilisation].
Thérapie 1995;50(6):557-62.
1995: Jean-François Lesesve; C Noblet; Aspasia Stamatoullas; I Gueit; nicholas moore; Mathieu Monconduit
[Adverse hematologic effects of ticlopidine].
Thérapie 1995;50(5):468-70.
1995: H Lévesque; N Cailleux; nicholas moore; H Tilly; M Monconduit; H Courtois
Autoimmune phenomena associated with cutaneous aseptic necrosis during interferon-alpha treatment for chronic myelogenous leukaemia.
British journal of rheumatology 1995;34(6):582-3.
1995: nicholas moore; C Briffaut; C Noblet; C A Normand; C Thuillez
Indirect drug-related costs.
Lancet 1995;345(8949):588-9.
1995: Robinson Joannides; Vincent RICHARD; nicholas moore; M Godin; Christian Thuillez
Influence of sympathetic tone on mechanical properties of muscular arteries in humans.
The American journal of physiology 1995;268(2 Pt 2):H794-801.
1995: Hervé Lefebvre; C Noblet; nicholas moore; L M Wolf
Pseudo-phaeochromocytoma after multiple drug interactions involving the selective monoamine oxidase inhibitor selegiline.
Clinical endocrinology 1995;42(1):95-8; discussion 98-9.
1994: Jean-François Lesesve; Marie Paule Callat; Bernard Lenormand; Mathieu Monconduit; C Noblet; nicholas moore; F Caron; G Humbert; Aspasia Stamatoullas; Hervé Tilly
Hematological toxicity of ticlopidine.
American journal of hematology 1994;47(2):149-50.
1994: Pascal Auzou; Didier Hannequin; I Landrin; J P Cochin; nicholas moore
Worsening of psychotic symptoms by clozapine in Parkinson's disease.
Lancet 1994;344(8927):955.
1994: P Tréchot; nicholas moore; L Bresler; A Castot; G Gay; P Netter; R Royer
Potassium chloride tablets and small bowel stenoses and perforations: two studies in the French Pharmacovigilance system.
The American journal of gastroenterology 1994;89(8):1268.
1994: H Lévesque; nicholas moore; N Cailleux; Vincent RICHARD; C Thuillez; H Courtois
Endothelins. A potential target for pharmacological intervention in diseases of the elderly.
Drugs & aging 1994;4(3):221-37.
1994: Hervé Lévesque; Nicole Cailleux; D Vasse; B Legallicier; nicholas moore; Jeanne-Yvonne Borg; N Hantute; C Thuillez; Hubert Courtois
[Evaluation of hospital cost of six days of treatment of deep venous thrombosis. Comparison of subcutaneous nadroparin and intravenous heparin in 40 patients].
Thérapie 1994;49(2):101-5.
1994: Luc Thiberville; P Compagnon; nicholas moore; G Bastian; M O Richard; M F Hellot; C Vincent; M M Kannass; S Dominique; C Thuillez
Plasma 5-fluorouracil and alpha-fluoro-beta-alanin accumulation in lung cancer patients treated with continuous infusion of cisplatin and 5-fluorouracil.
Cancer chemotherapy and pharmacology 1994;35(1):64-70.
1994: nicholas moore; J Fresel; R Joannidès; P Compagnon; C Thuillez
A comparison of the hemodynamic effects of urapidil, prazosin, and clonidine in healthy volunteers.
Blood pressure. Supplement 1994;4():7-12.
1993: Bettina A Hamelin; nicholas moore; C A Knupp; M Ruel; F Vallée; M LeBel
Cefepime pharmacokinetics in cystic fibrosis.
Pharmacotherapy 1993;13(5):465-70.
1993: Robinson Joannides; nicholas moore; Vincent RICHARD; M Godin; Christian Thuillez
[Mechanical adaptation of muscular arteries to acute increase of blood pressure in man. Contribution of the measurement of arterial wall thickness].
Archives des maladies du coeur et des vaisseaux 1993;86(8):1219-23.
1993: nicholas moore
Drugs in ancient populations.
Lancet 1993;341(8853):1157.
1993: F Moritz; J Petit; N Kaeffer; G Oksenhendler; H Papion; Bernadette Hecketsweiler; nicholas moore; C Winckler
Metabolic effects of propofol and flunitrazepam given for sedation after aortic surgery.
British journal of anaesthesia 1993;70(4):451-3.
1993: Hervé Lévesque; Nicole Cailleux; D Vasse; nicholas moore; B Legallicier; Jeanne-Yvonne Borg; Hubert Courtois
Prevention of venous thromboembolism after major abdominal surgery.
Lancet 1993;341(8848):824-5.
1993: Hervé Lefebvre; R Richard; C Noblet; nicholas moore; L M Wolf
Life-threatening pseudophaeochromocytoma after toloxatone, terbutaline, and phenylephrine.
Lancet 1993;341(8844):555-6.
1993: Philippe Chassagne; Othmane Mejjad; O Gourmelen; nicholas moore; X Le Loet; P Deshayes
Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection.
British journal of rheumatology 1993;32(2):158-9.
1993: nicholas moore; C Noblet; R Joannidès; M Ollagnier; J L Imbs; G Lagier
Cough and ACE inhibitors.
Lancet 1993;341(8836):61.
1993: Jean-François Muir; G Peiffer; M O Richard; D Benhamou; M Andrejak; L Hary; nicholas moore
Lack of effect of magnesium-aluminium hydroxide on the absorption of theophylline given as a pH-dependent sustained release preparation.
European journal of clinical pharmacology 1993;44(1):85-8.
1993: J Doucet; J Fresel; E Thibaut; C Noblet; nicholas moore
Changes in the prescription patterns for hypercholesterolaemia in Upper Normandy.
Thérapie 1993;48(1):69-70.
1993: Nicole Cailleux; C Noblet; nicholas moore; V Buquet-Queron; A Lahary; M Godin
[Furosemide (Lasilix) can be used in patients with G6PD deficiency. Apropos of a case].
Thérapie 1993;48(1):68.
1993: J Doucet; J Fresel; G Hue; nicholas moore
Protein binding of digitoxin, valproate and phenytoin in sera from diabetics.
European journal of clinical pharmacology 1993;45(6):577-9.
1993: Flavio Poldrugo; J D Chick; nicholas moore; J A Walburg
Mortality studies in the long-term evaluation of treatment of alcoholics.
Alcohol and alcoholism (Oxford, Oxfordshire). Supplement 1993;2():151-5.
1993: J A Walburg; E C Vermeulen; J D Chick; nicholas moore; Flavio Poldrugo
Towards a multi-functional diagnostic and evaluation instrument for international comparative research into the quality of the treatment of alcohol problems.
Alcohol and alcoholism (Oxford, Oxfordshire). Supplement 1993;2():133-8.
1992: Hervé Lévesque; Nicole Cailleux; J R Poutrain; C Noblet; nicholas moore; Hubert Courtois
[Pseudohyperaldosteronism by chronic overdose of "Pulmoll" expectorant lozenges].
Thérapie 1992;47(5):439-40.
1992: M Andrejak; J L Schmit; A Tondriaux; L Hary; S Debailleux; nicholas moore
[Neurologic side effects of fluoroquinolones. Apropos of 9 cases concerning pefloxacin].
Thérapie 1992;47(5):415-8.
1992: Benoit Thirion; Stéfan Darmoni; nicholas moore
Costs of medline and CD-ROM searching.
Lancet 1992;340(8814):308.
1992: M Fortier-Beaulieu; François Héron; C Noblet; F Cardot; N Manchon; nicholas moore; J Bourreile
Misoprostol-associated fever in cirrhotic patient.
Lancet 1992;340(8814):304.
1992: M Fortier-Beaulieu; C Noblet; F Cardot; E Thomine; nicholas moore; J Hemet; J Bourreille
Possible association of erythema multiforme with acamprosate.
Lancet 1992;339(8799):991.
1992: H Lévesque; nicholas moore; C Thuillez; H Courtois
[Endothelin. A new class of vasoactive peptides].
Thérapie 1992;47(1):53-6.
1992: N Cailleux; nicholas moore; H Levesque; H Courtois; M Godin
A low molecular weight heparin decreases plasma aldosterone in patients with primary hyperaldosteronism.
European journal of clinical pharmacology 1992;43(2):185-7.
1991: X Le Loët; CI Fessard; C Noblet; L Ait Saït; nicholas moore
Severe polyarthropathy in an adolescent treated with pefloxacin.
The Journal of rheumatology 1991;18(12):1941-2.
1991: G Humbert; I Brumpt; Guy Montay; Aimé Le Liboux; A Frydman; F Borsa-Lebas; nicholas moore
Influence of rifampin on the pharmacokinetics of pefloxacin.
Clinical pharmacology and therapeutics 1991;50(6):682-7.
1991: Hervé Lévesque; N Cailleux; P Vuillermet; nicholas moore; C Thuillez; Hubert Courtois
[Treatment of erythromelalgia with piroxicam in a patient with acetylsalicylic acid hypersensitivity].
Thérapie 1991;46(6):499-500.
1991: J Doucet; nicholas moore; A Gancel; H Courtois; J C Schrub
[Dyschromatopsia and complications of diabetes mellitus. Discriminant analysis].
Presse médicale (Paris, France : 1983) 1991;20(33):1624-5.
1991: Philippe Chassagne; C Humez; O Gourmelen; nicholas moore; X Le Loet; P Deshayes
Neurosensory adverse effects after combined phenylbutazone and misoprostol.
British journal of rheumatology 1991;30(5):392.
1991: D Lescut; H Fouin-Fortunet; nicholas moore; J Petit; Bernadette Hecketsweiler; J F Lemeland; Philippe Denis; Raymond Colin
Liver glutathione and cytochrome P450 activity in experimental infection: study of the relative effects of infectious stress and malnutrition.
Critical care medicine 1991;19(9):1183-7.
1991: H Lévesque; nicholas moore; H Courtois
Reporting adverse drug reactions by proprietary name.
Lancet 1991;338(8763):393.
1991: J R Poutrain; Hervé Lévesque; A Gancel; G Ozenne; P Vuillermet; C Noblet; nicholas moore; Hubert Courtois
[Hyperthyroidism under treatment with lithium].
Thérapie 1991;46(4):339.
1991: nicholas moore; C Libert
Acamprosate, citalopram, and alcoholism.
Lancet 1991;337(8751):1228.
1991: C Houdent; C Noblet; C Vandoren; H Levesque; C Morin; nicholas moore; Hubert Courtois; L M Wolf
[Hypoglycemia induced by cibenzoline in the elderly].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1991;12(2):143-5.
1991: H Levesque; Nicole Cailleux; C Noblet; A Gancel; nicholas moore; Hubert Courtois
[Hypoaldosteronism induced by low molecular weight heparins].
Presse médicale (Paris, France : 1983) 1991;20(1):35.
1991: H Levesque; M C Elie-Legrand; C Noblet; A Gancel; nicholas moore; Hubert Courtois
[Megaloblastic anemia secondary to ingestion of metformin].
Thérapie 1991;46(1):89-90.
1990: T Delangre; L Vernier; nicholas moore; Bruno Mihout
[Acute rhabdomyolysis during treatment with ciprofibrate].
Presse médicale (Paris, France : 1983) 1990;19(39):1811-2.
1990: Philippe Chassagne; H Levesque; nicholas moore
[Methotrexate. Pharmacology applied to the treatment of rheumatoid arthritis].
Thérapie 1990;45(6):499-504.